Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial por Walter Suárez Carmona | Ene 10, 2025
A Mechanistic Rationale for Incretin-Based Therapeutics in the Management of Obesity por Walter Suárez Carmona | Ene 10, 2025
Hypothalamic obesity: from basic mechanisms to clinical perspectives por Walter Suárez Carmona | Ene 10, 2025
Rheumatic diseases and metabolism: where centre and periphery meet por Walter Suárez Carmona | Ene 7, 2025
Neurobiology of attention-deficit hyperactivity disorder: historical challenges and emerging frontiers por Walter Suárez Carmona | Ene 7, 2025
